Bioinformatics: Technologies and Global Markets

Report Code: BIO051G

Publish Date: Dec 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

30% Off

Limited Period Offer

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for bioinformatics is expected to grow from $18.7 billion in 2023 to $35.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2023-2028.

Report Includes

  • 123 data tables and 90 additional tables
  • An up-to-date overview and industry analysis of the global bioinformatics market
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the market size and revenue forecast for the global bioinformatics market, and corresponding market share analysis based on solution, hardware type, application, sequencing services and platforms, end use, and region
  • In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
  • Coverage of information on the latest developments in the bioinformatics tools and services market, innovations in bioinformatics solutions for drug discovery, and details of antibody-based drug discovery and developments
  • Impact analysis of various region specific and industry specific macroeconomic variables on global bioinformatics market
  • Identification of the innovative companies and technologies that are moving forward in search for elusive pieces of information that will improve diagnoses and treatments of diseases with precision medicines
  • Understanding of the importance of ESG in the market for bioinformatics tools and services, consumer attitudes towards sustainability, risks & opportunity assessment, ratings and matrices, and ESG practices in global bioinformatics marketplace
  • A look at the major vendors in the global bioinformatics market, and analyze the structure of this industry with respect to company market shares, venture fundings, and recent M&A activities
  • Patent analysis covering significant allotments of recent patent grants across each major category
  • Profile descriptions of the leading market players

Report Scope

The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.

By solution, hardware application, sequencing services and platform, end user, and geography, the market has been segmented into the North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. Detailed analysis of major countries such as the U.S., Germany, the UK, Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and Australia will be covered in each country’s respective regional segment. In the market valuations, 2022 serves as the base year, while estimated values are provided for 2023 and forecast values for 2028.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $16.5 billion
Market size forecast $35.5 billion
Growth rate CAGR of 13.6% from 2023 to 2028
Units considered $ Millions
Segments covered By Solution, Hardware Type, Application, Sequencing Services and Platforms, End User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered The U.S., Canada, Mexico, Brazil, Germany, France, Italy, Spain, United Kingdom, China, Japan, India, Australia and New Zealand (ANZ), and GCC countries
Key Market Drivers
  • New Discoveries in Biological Sciences
  • Increasing Use of Bioinformatics Analytical Software
  • New Antibody Technologies and Antibody Types
  • Antibody-Based Drug Discovery and Development
  • Developed and Increasing Research Areas
  • Increased Government Funding in Emerging Markets
  • Need for Further Human Genomic and Proteomic Research
  • New Application-Focused Technology Platforms
Companies studied
3RD MILLENNIUM INC.AITIA
AGILENT TECHNOLOGIES INC.ARAGEN LIFE SCIENCES LTD.
BIOMATTERS LTD. GENEIOUSBIO-RAD LABORATORIES INC.
BIO-TECHNECOMPUGEN LTD.
DASSAULT SYSTEMESDNASTAR INC.
GENEDATA AGGENEVA BIOINFORMATICS (GENEBIO) SA
ILLUMINA INC.INTE:LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
MACVECTOR INC.MOLECULAR CONNECTIONS PVT. LTD.
MOLECULAR NETWORKS GMBHNONLINEAR DYNAMICS LTD.
OCIMUM BIOSOLUTIONS LTD.PERKINELMER
PERSONALIS INC.QLUCORE AB
REAL TIME GENOMICSSMARTGENE SERVICES SARL
SYNGENE INTERNATIONAL LTD.THERMO FISHER SCIENTIFIC INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The market is projected to grow from $16.5 billion in 2022 to $35.5 billion in 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period.
The key factors driving the growth of the Bioinformatics Technologies and Global Market.
  • Rise in Adoption of ChatGPT.
  • Increase in Integrated Artificial Intelligence Software
  • Data Science Inclusion in Bioinformatics
  • Rise in funding for Genomic Study in different countries.
The Bioinformatics Technologies and Global Market is segmented based on:
  • Application.
  • End user.
  • Solution.
  • Hardware Type.
  • Sequencing Analysis of Platform and Services.
  • Country wise segmentation.
By Application, genomics segment is anticipated to dominate the market by the end of 2028.
North America holds the highest market share in the market in terms of region.

Analyst Credentials

Partha Sarathi Das– Associate Consultant-Life Science Research
Partha Sarathi has an experience of nearly a decade in multiple domains, including healthcare, life science, biotechnology, pharmaceuticals, and healthcare IT. His expertise is in designing research studies, gathering data, and performing analysis, ultimately providing clients with actionable insights and recommendations based on their unique business needs. Designs proposal and participates in client queries for quick delivery based on their unique business needs. Academically, Parthasarathi holds a master’s degree in Biotechnology and a bachelor’s degree in Industrial Biotechnology.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Bioinformatics: Technologies and Global Markets481Free
Chapter- 1: Introduction9Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview27Free
Chapter- 4: Market Dynamics11Free
Chapter- 5: Market Breakdown by Application69Free
Chapter- 6: Market for Sequencing Services and Platforms12Free
Chapter- 7: Market Breakdown by Solution53Free
Chapter- 8: Market Breakdown by End Use21Free
Chapter- 9: Market Breakdown by Region150Free
Chapter- 10: ESG Development14Free
Chapter- 11: Bioinformatics Applications in Pharmaceutical R&D34Free
Chapter- 12: Emerging Technologies and Developments8Free
Chapter- 13: Qualitative Information on New Software4Free
Chapter- 14: M&A and Venture Funding Outlook16Free
Chapter- 15: Competitive Intelligence5Free
Chapter- 16: Company Profiles43Free
Chapter- 17: Appendix: Acronyms1Free

Related Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

High-Throughput Screening: Technologies and Global Markets

Published - Feb 2025 | Publisher - BCC Publishing | Code - PHM205B

The global market for high-throughput screening (HTS) is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029.

High Content Screening/Imaging: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO166C

The global market for high content screening and imaging (HCS/I) is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029, at a compound annual growth rate (CAGR) of 8.4% from 2024 through 2029.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 213

  • Summary Table: Global Market for Bioinformatics, by Application, Through 2028
  • Table 1: Recommendations for NGS Bioinformatics Tools
  • Table 2: Bioinformatics Tools Used for Metagenomics Analysis
  • Table 3: DBMS Platforms in Bioinformatics
  • Table 4: Global Market for Bioinformatics, by Application, Through 2028
  • Table 5: Cloud-Based Bioinformatics Tools
  • Table 6: Global Market for Bioinformatics in Genomics Applications, by Region, Through 2028
  • Table 7: Global Market for Bioinformatics in Proteomics Applications, by Region, Through 2028
  • Table 8: Global Market for Bioinformatics in Transcriptomics Applications, by Region, Through 2028
  • Table 9: Commercially Available Metabolomics Software
  • Table 10: Open Access Tools for Complex Liquid Chromatography-Mass Spectrometry Data Analysis
Sample Report

Recent Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Human Microbiome-based Drugs and Diagnostics: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO151B

The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.

Global Microbiome Sequencing Market

Published - May 2025 | Publisher - BCC Publishing | Code - BIO183B

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Top Trending Reports

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Published - Jun-2021| Analyst - BCC Publishing| Code - BIO051F

Report Highlights

The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.

Report Includes

  • 51 data tables and 84 additional tables
  • An overview of the global markets and technologies for bioinformatics
  • Analyses of global market trends, with data from 2018, 2019, 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Evaluation of market size and forecast, and market share analysis of bioinformatics based on categories, applications, sequence services and platforms, region, and end-users
  • Highlights of technological advancements and innovations in bioinformatics solutions for drug discovery and insights into investments and funding for the development of bioinformatics solutions
  • Assessment of challenges and opportunities in the bioinformatics market and description of high-throughput technologies such as next-generation sequencing (NGS), big data analysis and cloud-based solutions
  • Coverage of new discoveries in biological sciences; details of antibody-based drug discovery and development; prevalence of chronic diseases and impact analysis of COVID-19 on bioinformatics company
  • Identification of innovative companies and technologies that are moving forward in search for elusive pieces of information that will improve diagnoses and treatments of diseases with precision medicines
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Comprehensive company profiles of major players of the industry, including Illumina Inc., Genedata AG, Qlucore AB, GNS Healthcare Inc., Smartgene Services SARL and Real Time Genomics Inc.
Published - Dec-2019| Analyst - Vijay Laxmi| Code - BIO051E

Report Highlights

The global bioinformatics market should grow from $7.5 billion in 2018 to $20.0 billion by 2023, with a compound annual growth rate (CAGR) of 21.7% during the period of 2018-2023.

Report Includes

  • 31 data tables and 80 additional tables
  • Comprehensive details of the global bioinformatics market and relevant technologies
  • Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Assessment of the market trends and analysis regarding industry service providers and software solution developers, as well as information technology (IT) and bioinformatics service providers that support the pharma and biotech industries
  • Review of challenges and opportunities underlying in the bioinformatics market following the adoption of high-throughput technologies such as next-generation sequencing (NGS), the analysis of big data, and the emergence of cloud-based solutions
  • Insight into the sequencing and pharmaceutical R&D applications of bioinformatics in drug development and clinical trials, including cheminformatics, next-generation sequencing, metagenomics and data management systems
  • A look at the investigational new drug applications, NDA approvals, leading EHRs providers, mobile health technologies, and recent partnerships and agreements in the pharmaceutical and bioinformatic sectors
  • Profile description of key pharmaceutical and biotechnology companies, including Dassault Systemes Biovia, Genedata AG, PerkinElmer Informatics Inc., Qlucore AB and Syngene International
Published - Nov-2018| Analyst - Vijay Laxmi| Code - BIO051D

Report Highlights

The global market for bioinformatics should grow from $6.4 billion in 2017 to reach $16.0 billion by 2022 at a compound annual growth rate (CAGR) of 20.0% for the period of 2017-2022.

Report Includes 

  • 28 data tables and 72 additional tables
  • An overview of the global market for bioinformatic technologies and their applications
  • Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Discussion of the goal of bioinformatics and their role in systems biology
  • Insight into the application of bioinformatics on drug development, including cheminformatics, next-generation sequencing, metagenomics and data management systems
  • Detailed profiles of major companies in the market, including 3rd Millennium, Inc., Biomatters Ltd., Compugen Ltd., DNASTAR, Inc., and Illumina, Inc.
Published - Jan-2016| Analyst - Dr. Cheryl Lee Barton| Code - BIO051C

Report Highlights

The global bioinformatic market was $3.6 billion and $4.1 billion in 2013 and 2014, respectively. This market is expected to reach $8.0 billion in 2019 from $4.7 billion in 2015 at a compound annual growth rate of 14.2% for the period 2014-2019.

Report Includes

  • An overview of the global market for bioinformatics based on geography, category and application.
  • Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2019.
  • Technological descriptions and patenting trends in bioinformatics.
  • Analysis of the market's dynamics, including opportunities, drivers, and restraints.
  • Examination of the economic environment effecting the deployment of bioinformatics.
  • Discussion of other influential factors, such as R&D spending in the pharmaceutical sector, the growth of agrobiotechnology, and the expanded use of microbial genomics.
  • Comprehensive company profiles of major players in the industry.
Published - Apr-2013| Analyst - Dr. Cheryl Lee Barton| Code - BIO051B

Report Highlights

The global bioinformatics market was valued at nearly $2.8 billion in 2011, nearly $3.2 billion in 2012, and is forecast to grow to nearly $7.5 billion by 2017 after increasing at a compound annual growth rate (CAGR) of 18.7%.

Report Includes

  • An overview of the global market for bioinformatics.
  • Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Technological descriptions and patenting trends in bioinformatics.
  • Examination of the economic environment affecting the deployment of bioinformatics.
  • Discussion of other influential factors, such as R&D spending in the pharmaceutical sector, the growth of agrobiotechnology, and the expanded use of microbial genomics.
Published - Aug-2005| Analyst - Evalueserve | Code - BIO051A

Report Highlights

  • The worldwide value of bioinformatics is expected to increase from $1.02 billion in 2002 to $3.0 billion in 2010, at an average annual growth rate (AAGR) of 15.8%.
  • The fastest growing market is expected to be analysis software and services. It is estimated to grow from $444.7 million in 2005 to $1.2 billion in 2010.
  • The application of bioinformatics in drug discovery and development is expected to reduce the annual cost of developing a new drug by 33%, and the time for drug discovery by 30%.
  • The pharmaceutical companies are expected to increase their R&D expenditures in the future and a major portion of this spending is expected to go into bioinformatics.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Bioinformatics: Technologies and Global Markets
Sample Report